CRMP1 and non-small cell lung carcinoma: LCRMP-1 can promote filopodia formation, cancer cell migration, invasion through functionally against CRMP-1, and its expression correlates with poor clinical outcome in non-small-cell lung cancer (NSCLC) patients.